Among several types of cancer, LSD1 expression was found significantly increased in hepatocellular carcinoma (HCC) compared with adjacent non-neoplastic liver tissue, thereby rendering LSD1 a diagnostic marker and therapy target. Here, KDM1A is linked to cancer.